Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AHB-137 in Nucleos(t)Ide Analogue-treated Participants With Chronic Hepatitis B
NCT07654283Phase 2Recruiting
- Sponsor
- AusperBio
- Start
- Sep 2026
- Primary completion
- May 2027
- Countries
- 6
01
Overview
A Phase 2 trial of AHB-137 in Chronic Hepatitis B (CHB), sponsored by AusperBio. Started Sep 2026; status: recruiting.
02
Drugs
AHB-137
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT07654283.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07654283.